Cosmos Health Inc. (COSM) stock
COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30135% above fair value
$3.24−0.96 (-22.86%)
Close on Nov 13, 2026Market cap $326.05MP/E –Yield –
Cosmos Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cosmos Health's ebitda for the twelve months ending Jun 30, 2026 was -$16.95M. For fiscal 2025 it was -$15.34M. The highest annual figure on record is $3.11M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.34M | – |
| FY2024 | Dec 31, 2024 | -$14.33M | – |
| FY2023 | Dec 31, 2023 | -$21.22M | – |
| FY2022 | Dec 31, 2022 | -$7.29M | – |
| FY2021 | Dec 31, 2021 | -$4.18M | -234.4% |
| FY2020 | Dec 31, 2020 | $3.11M | +2141.7% |
| FY2019 | Dec 31, 2019 | $138.82K | – |
| FY2018 | Dec 31, 2018 | -$1.18M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.58M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.84M | – |
| Q4 FY2025 | Dec 31, 2025 | -$11.09M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.29M | – |
| Q1 FY2025 | Mar 31, 2025 | -$517.31K | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.66M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.94M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.52M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.35M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.77M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.45M | -7201.8% |
| Q1 FY2023 | Mar 31, 2023 | -$2.58M | -826.8% |
| Q4 FY2022 | Dec 31, 2022 | -$7.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$231.23K | – |
| Q2 FY2022 | Jun 30, 2022 | $34.49K | -93.4% |
| Q1 FY2022 | Mar 31, 2022 | $354.87K | -69.6% |
| Q4 FY2021 | Dec 31, 2021 | -$482.54K | -144.0% |
| Q1 FY2021 | Mar 31, 2021 | -$1.62M | -598.8% |
| Q4 FY2020 | Dec 31, 2020 | $521.47K | -27.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.17M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.10M | – |
| Q1 FY2020 | Mar 31, 2020 | $325.57K | – |
| Q4 FY2019 | Dec 31, 2019 | $714.88K | – |
| Q3 FY2019 | Sep 30, 2019 | -$23.71K | -147.1% |
| Q2 FY2019 | Jun 30, 2019 | -$434.98K | – |
| Q1 FY2019 | Mar 31, 2019 | -$117.37K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.02M | – |
| Q3 FY2018 | Sep 30, 2018 | $50.36K | – |
See a number that looks wrong?